A weekend strike in the Strait of Hormuz sent oil sharply higher and handed an already-hawkish Fed a fresh inflation argument, and for the first time in this dataset more stocks now sit in a technical downtrend than an uptrend.

The Signal
Stocks gave up modest ground Monday after a weekend US strike on Iranian positions in the Strait of Hormuz, the first acknowledged strike there since late July, drew a retaliation and sent oil sharply higher. The S&P and Nasdaq slipped, the Dow fell harder, and energy was the only part of the market that worked. Volatility ticked up but stayed low, and August itself still closed as a solid winning month. The oil jump matters most for what it does to the Fed: a hawkish Jackson Hole speech on Friday had already pushed next month's hike odds toward a coin flip, and the fresh supply shock strengthens that case, against a Treasury Secretary's counterargument that a supply shock alone shouldn't force a hike.

The Noise
Underneath the index moves, the internals quietly deteriorated. For the first time in this dataset, more stocks now sit in a technical downtrend than an uptrend, and the share of names with net buying pressure eased back from where it stood Friday, though it still leans positive. A stretched-valuation gauge shows a large number of stocks sitting at extreme, crowded levels for every one trading at a genuine discount. By sector, money quietly left financials, health care and consumer staples today, exactly the trades that worked when a rate cut looked like the sure thing, while utilities and industrials are being bought even as prices drift lower, a rotation footprint sitting underneath a market that looks calm on the surface.

Multi-Signal Confluence
Rollins, the pest-control company, is trading at a fresh 52-week low after a disappointing quarter showed its core residential business growing more slowly than expected, drawing multiple analyst downgrades and a fair-value cut of nearly a quarter. The technical setup screens as a real discount, but the fundamentals genuinely deteriorated here too, making this a name to watch for a confirmed reversal rather than a blind dip-buy.

Palantir screens bearish on extension after a stock that has run hard, even though the business itself just posted a blowout quarter: revenue up 93% year over year, US commercial growth even faster, a defense platform reportedly tracking toward $1B in recurring revenue, and strong margins and free cash flow. It is the textbook case where a bearish technical reading means priced for a lot of good news, not a bad company.

Southern Company shows up oversold today, with money flowing in as price sits roughly flat, part of the same utilities cluster being bought on an AI power-demand thesis. The company says power usage from large industrial and data-center customers is up 55% year over year and its contracted demand pipeline has swelled into the double-digit gigawatts. Worth remembering: utilities normally get hurt when rates rise, so this is a bet on power demand outrunning that headwind, not a hedge against it.

Week Ahead
A loaded data stretch leads into the Fed's next decision: a manufacturing survey Wednesday, then the August jobs report Friday, which the market treats as the single most important number before the meeting. The next major data point after that is the August inflation report on September 11, with the Fed's decision itself landing September 15–16.

Data as of the August 31, 2026 close.
Educational research only, not investment advice. Stay sharp.

A Fed official's hawkish Jackson Hole speech pushed next month's hike odds to a coin flip and hit growth stocks hardest, but broad money flow and price structure still lean bullish, so this reads as rotation and stretched positioning, not a trend break.

The Signal
Stocks pulled back Friday to close an otherwise winning week after a Federal Reserve official's high-profile speech said inflation is still running too hot and that price stability, not growth, is the Fed's main job right now. Traders pushed the odds of a hike at next month's meeting to roughly a coin flip, up from about one-in-three the day before, and bond yields jumped. Growth and richly valued names took the worst of it, chipmakers led the retreat despite a strong earnings beat from the sector's biggest name two days earlier, while parts of the market that benefit from higher rates held up better. Broad measures of money flow and price structure across the market are still tilted positive, so the underlying trend remains intact even after Friday's reversal.

The Noise
A much narrower set of overbought and overextended signals is more one-sided than usual, meaning a large number of quality names are simply stretched after a strong run, a caution about position sizing rather than a top signal. By sector, money has quietly left financials, health care and consumer staples, the trades that worked when a rate cut looked like the sure thing, while utilities and industrials are seeing accumulation even as their prices drift lower. Worth flagging: a biotech company that was one of the worst performers in the S&P 500 last year has flipped to one of the best this year, after a flu-vaccine approval and a landmark cancer-vaccine trial win rewrote its story, a reminder that a single binary catalyst can rewrite a multi-year trajectory almost overnight.

Multi-Signal Confluence
Public Service Enterprise Group, the New Jersey utility, has drifted lower this month, including after a quarterly report showing profit down year over year, but the company reaffirmed full-year guidance backed by a capital spending plan worth over twenty billion dollars. Money is flowing in even as the price falls, a classic accumulation pattern tied to an AI power-demand thesis rather than a rate bet, since utilities normally get hurt when rates rise.

Adobe is a good example of why an overextended signal doesn't mean a bad company: shares have rallied on a major asset manager's stake increase, a bullish new coverage initiation, and a broader tech tape lifted by a chipmaker's earnings beat, but the stock now sits deep in overbought territory with much of that good news already priced in ahead of its own earnings report in about two weeks. NXP Semiconductors, by contrast, shows a technical discount rather than extension even as sector peers tied to datacenter chips led Friday's selloff, supported by a Malaysia manufacturing expansion, a new automotive partnership, and a steady dividend.

Week Ahead
A loaded stretch of data leads into the next Fed decision: a manufacturing survey midweek, job openings and the Fed's own regional economic report on Thursday, and the August jobs report on Friday, which traders see as the single most important data point before the meeting. A hot print firms up the case for a hike; a soft one is the market's best argument against it.

Data as of the August 28, 2026 close.
Educational research only, not investment advice. Stay sharp.

Nvidia's blowout guide sparked a narrow software melt-up while quiet accumulation built in utilities and semiconductors underneath, and the real test lands tomorrow when the Fed chair gives his first Jackson Hole speech with a rate hike genuinely on the table.

The Signal
A narrow, violent rally: the Nasdaq outran the S&P and the Dow barely moved, as Nvidia's blowout revenue guide (roughly $108B for next quarter, up about 89% year over year) sent software names like Salesforce, CrowdStrike, Veeva and ServiceNow sharply higher. The move pulled money from railroads, card networks, staples, utilities and health care. Broad measures still read bullish: well over half of tracked names show accumulation, and uptrends outnumber downtrends by a wide margin. But the backdrop is tense — the 30-year Treasury yield sits at its highest since 2007, futures price roughly one-in-three odds of a rate hike next month, and the Fed chair gives his first Jackson Hole keynote tomorrow morning with volatility priced as if nothing is at stake.

The Noise
Today's confirmed bearish-to-bullish ratio was the most lopsided in weeks, but it's mostly mechanical: a stock that gaps 20% higher pins itself to an overbought extreme regardless of fundamentals, so the wall of sell signals concentrated exactly where the melt-up happened, in technology and health care. The more useful tell is where money quietly built for about a week even as prices fell: utilities and semiconductors, both of which sold off again today while software squeezed. And a dispersion story is worth naming: the Nasdaq 100 is up roughly 16% this year, but its median member is up only about 8%, with a third of names actually negative, a reminder of how narrow this year's leadership has become.

Multi-Signal Confluence
Salesforce sits at the top of today's extended list after gapping over 20% on a blowout quarter, an 80% earnings beat and raised full-year guidance, with AI revenue nearing $4B annually and a new Anthropic partnership. The business is genuinely strong, but the stock now trades more than five standard deviations above its model target, the most extended reading on the board — a fantastic quarter that got priced in within hours, making new entries here a poor risk-reward.

Aptiv, the auto and EV parts supplier, trades more than one standard deviation below its model target, but this isn't a clean dip-buy: the company beat earnings yet cut full-year profitability guidance by about 3%, with a steeper cut flagged for the back half, and the stock sits at a fresh 52-week low despite the beat, with several Wall Street desks trimming price targets even as one insider added shares. A lower low inside an established downtrend reads as a falling knife, not a comfortable dip.

Pinnacle West, the Arizona utility, carries the cleanest bullish reversal signal on the board, backed by a raised long-term growth outlook on data-center demand and ten straight quarters of meeting or beating guidance. But the stock is still down over 8% this month with the rest of the rate-sensitive utility group, and the weekly chart disagrees with today's bullish daily signal, one of only two names where that happens. Buying a rate-sensitive name the night before the Fed chair's first major speech is paying for a coin flip; the setup will still be there after.

Data as of the August 27, 2026 close.
Educational research only, not investment advice. Stay sharp.

Chip stocks led today's selloff as the US-Canada trade war went live, even as broad market breadth stayed intact and today's confirmed reversal signals concentrated almost entirely in health care. AppLovin and Amgen capture the split: a contested falling-knife bounce against Wall Street's still-bullish view, and a fundamentally strong name stretched too far after a hot summer rally.

The Signal
Stocks slipped to start the week as chip stocks led the way down, with Nvidia falling sharply into its earnings report later this week and the Nasdaq underperforming the broader tape by a wide margin. The Dow actually eked out a small gain, so this wasn't broad risk-off, it was money leaving the market's most crowded corner. Two policy stories drove the tape. The Treasury Department rolled out a new sanctions push targeting dozens of entities tied to Iran's oil, shipping and gold trade, a tailwind for energy. Bigger, the trade war with Canada went live: talks between Washington and Ottawa collapsed Friday, steep tariffs on tens of billions of dollars of Canadian goods took effect over the weekend, the administration is threatening to double auto tariffs from January, and Canada has matching retaliation queued for early September. The volatility index sits near its lowest level of the year, pricing in little of any of it.

The Noise
Strip away the chip-driven wobble and the broad picture is still constructive: most of the market remains classified as accumulated, and stocks in a longer-term uptrend outnumber those in a downtrend by a healthy margin. What's unusual is how lopsided the shorter-term extension reads are. Confirmed reversal signals are running heavily bearish, and that skew sits almost entirely in health care, which supplies close to half of every bearish read today, alongside some technology-services and payments names stretched well above where our models expect them to sit after a summer of defensive-trade buying. On the other side, every single bullish setup the scan flagged is sitting inside a downtrend with money still flowing out, capitulation bounces rather than comfortable dip-buys. The rotation underneath is the part worth watching: distribution is clustering in health care while fresh accumulation shows up in industrials and materials, cyclical, old-economy sectors that would get hurt by the Canada tariff escalation the market hasn't fully priced.

Multi-Signal Confluence
AppLovin is the standout among today's short list of nine bullish setups, one of the rare ones where the weekly chart actually agrees with the short-term bullish signal. The company runs an AI-driven advertising platform that started in mobile gaming and is expanding into e-commerce and consumer apps; it just posted a strong quarter and gained more ad-spend share than any other network, but guidance came in light and the new consumer-ads business, generally available only since June, is ramping slower than hoped. The stock is roughly cut in half this year and still making fresh lows. Wall Street's fundamental view has barely budged, with several banks reiterating buy ratings and average price targets implying significant upside, but the price action itself is a classic falling-knife pattern, not a dip-buy, until a confirmed reversal or a flip in money flow shows up.

Amgen is the flip side: a strong business that ran too far, too fast. Its early-August results were strong enough that several analysts raised price targets, and the stock has traded near record highs. Its biggest pipeline story is an obesity drug that showed up to 20% weight loss in mid-stage trials, positioned as a monthly injection rather than the weekly shots that dominate the category today, a real differentiator if it holds up in later trials. But the stock is stretched several standard deviations above where its trend model expects it to sit, with a confirmed bearish reversal signal and heavy money flow already rotating out, a name from today's health-care rotation story that argues for locking in gains and tightening stops rather than chasing it higher.

Week Ahead
A big chunk of the market's risk sits inside one 72-hour window this week. Wednesday morning brings the July core inflation report, the Fed's preferred gauge; Wednesday afternoon, after the close, Nvidia reports earnings, a name that sits at the center of major index funds regardless of who owns the stock directly. Friday, the new Fed chair delivers his first keynote as chair at Jackson Hole; the official topic is payments policy, but markets will be listening for one thing, whether he leans dovish or hawkish on rates. Layer on the escalating Canada trade fight and the new Iran sanctions, and it's a week to stay nimble.

Data as of the August 24, 2026 close.
Educational research only, not investment advice. Stay sharp.

The thirty-year Treasury yield hit a nineteen-year high and stocks bounced only on strong Friday data, while our signals flagged eighteen health care names, more than the next three sectors combined, as overextended after months of sector leadership.

The Signal
Stocks fell most of the week and then rallied hard Friday, but the real story sat in the bond market: the thirty-year Treasury yield touched 5.27%, a nineteen-year high, on deficit worries, sticky inflation and a wave of competing corporate debt issuance. The Treasury tried to get ahead of it midweek by more than doubling its buyback program, and long bonds rallied for about a day before giving it all back by Thursday. Friday's stabilizer was surprisingly strong business-activity data, its fastest pace in more than four years, which lifted the Dow 0.98% and let the Nasdaq snap a five-day losing streak. Bitcoin quietly had its best week in two years.

The Noise
Universe money flow and trend structure, the broadest measures, both still lean bullish: buy-side flow outweighs sell-side roughly 1.7-to-1, and more names carry an up-structure than a down one. But the narrower, faster-moving measures have flipped hard bearish and are unusually concentrated: eighteen of today's forty bearish signals sit in health care alone, more than the next three sectors combined, and every one of those names is still technically in an uptrend. That's not a broad top, it's a hot sector running ahead of itself after leading the market since semiconductors peaked in June. Distribution is quietly building in AI hardware and rate-sensitive financials three sessions before Nvidia reports, while the bullish signals cluster in a completely different place, industrials, materials and consumer staples, a rotation signature rather than a market-wide reversal.

Multi-Signal Confluence
Merck is the face of the health care story. Merck and Moderna announced Wednesday that their individualized mRNA cancer vaccine paired with Keytruda hit its primary endpoints in a late-stage melanoma trial, cutting the risk of recurrence and of the cancer spreading. The stock jumped double digits that day, its best session in well over a decade, and Wall Street banks raised price targets on a pipeline Merck values above $70 billion across more than twenty products, alongside positive trial readouts in endometrial cancer and ulcerative colitis the same week. The fundamental case is genuinely strong. The technical one is not: our signals show the stock trading well above its typical pace, with a confirmed bearish reversal candle at the highs. Good news, arguably already priced in.

NiSource, the Indiana utility, is the inverse setup. Its second-quarter adjusted earnings missed estimates, but management reaffirmed full-year guidance and its long-term growth target, leaning into a data-center pipeline that already has several gigawatts signed and could roughly double, toward nine gigawatts, of AI and cloud capacity by 2035. The stock kept sliding anyway, caught in a broader utility downdraft as rising long rates punish anything that behaves like a bond. All three of our signals now agree it sits at a meaningful discount, the cleanest setup in the utility group today, though it's still technically in a downtrend, a bet against the direction long rates have been moving.

Week Ahead
Wednesday is the single biggest event of the quarter: Nvidia reports after the close, with pricing putting direction close to a coin flip. The same morning brings July core PCE into an already-stressed bond market, plus the second estimate of second-quarter GDP, likely a non-event next to the other two. Friday, the new Fed chair gives his first Jackson Hole keynote with no market priors yet on his framing. In the background, the Treasury's expanded buyback program starts in earnest September 9, seen as a possible circuit breaker for yields, not a fix.

Data as of the August 21, 2026 close.
Educational research only, not investment advice. Stay sharp.

Walmart's slowest comparable-sales growth since 2020 and a reversing bond-market rally sent stocks lower across the board, but the broad trend remains intact even as extension concentrates in health care and financials; Medtronic is today's most one-sided bearish read despite strong fundamentals, while Lennox's deep discount is a falling knife, not a dip to buy.

The Signal
Stocks fell across the board, with the Dow dropping more than seven hundred points after Walmart posted its weakest comparable-sales growth since 2020 and the bond market gave back a Treasury-buyback-driven rally, sending the thirty-year yield back above five and a quarter percent. Hawkish Fed minutes and an escalating standoff with Iran added pressure, pushing oil higher, while Bitcoin surged more than eleven percent on the buyback news alone. Underneath the headline, capital flowing into stocks still outweighs capital flowing out by a wide margin, and roughly three in five names in our universe remain in an uptrend.

The Noise
The broad trend says health is intact, but it's stretched: for every name trading at a meaningful discount to its own model, nearly three sit at a meaningful premium, and the narrower warning signals are almost entirely one-sided, concentrated in health care and financials, the two groups that led this market higher for months. A quieter tell is building in tech: several large computer-hardware names have seen buying pressure roll over even as prices kept climbing, all within the same week, right ahead of Nvidia's earnings on the twenty-sixth. That's a watchlist item, not yet a signal to act on.

Multi-Signal Confluence
Medtronic is today's single most one-sided read: every signal our model tracks points down, even though the underlying business is doing well. The medical device maker beat earnings this week, grew revenue more than eight percent, and raised full-year guidance, with Wall Street's average price target still above the stock. What's driving the bearish read isn't the fundamentals, it's the price: the stock sits roughly two and a half standard deviations above its own trend, exactly the kind of long-duration, defensive-growth name that gets hurt first when long rates sit this high.

Lennox International, the air conditioning maker, is the cheapest name in today's scan relative to its own trend, but the reason is a real business problem, not just a stretched chart. The stock cratered more than twenty percent in a single session in late July after missing sales targets and cutting guidance on softness in the residential market, and a law firm is now investigating whether the company misled investors ahead of that miss. A fresh reversal-style pattern printed today, the kind that sometimes marks a short-term bottom, but the stock remains in a confirmed downtrend with selling pressure underneath it — a falling knife, not a dip to buy.

Data as of the August 20, 2026 close.
Educational research only, not investment advice. Stay sharp.

Three down days ended on a Treasury-driven yield relief rally, but the confluence signals are almost entirely bearish and concentrated in health care, software and financials — a rotation story, not a top, with Martin Marietta the cleanest discount on the board and Bio-Techne's extension explained by its pending buyout, not momentum.

The Signal
Stocks closed narrowly higher after three straight down days, as the Treasury said it would step up buybacks of long-dated debt and the 30-year yield pulled back from Tuesday's 19-year high. Brent crude sits near $92 on a fourth straight up day as the Strait of Hormuz stays effectively closed and the UAE cuts economic ties with Iran. Universe money flow still runs 65% buy-side, and about two-thirds of the market remains in an uptrend. Friday's Jackson Hole keynote, delivered after a divided 9-3 Fed vote, is the next real test.

The Noise
The confluence table is almost entirely one-sided — 48 bearish rows against 4 bullish — and it's tempting to read that as a market rolling over. It isn't: most of the bearish signal is concentrated in health care, enterprise software and financials, the three groups that led the market for months, while a handful of names in staples, materials and industrials are quietly building. Bulls and bears sitting in different sectors is rotation, not a top.

Multi-Signal Confluence
Martin Marietta, the aggregates and building materials company, just announced a major acquisition of Lhoist North America's specialty lime and mineral business, financed with more than $10 billion in new debt raised across two offerings this month, and the board approved its eleventh consecutive annual dividend increase. The stock is down more than 12% year-to-date even as Wall Street's average target sits well above the current price, and the signals agree: a fresh short-term low with money quietly flowing in underneath it, the cleanest accumulation read on the board.

Bio-Techne, the life sciences tools maker, is the single most extended name in the market today at over five standard deviations above trend — but the reason is unusual. Bio-Techne agreed in June to be acquired by Germany's Merck KGaA for $73 a share in an $11 billion-plus deal expected to close by early 2027, and the stock trades right around $72, just below the offer. The extension is arbitrage math, not momentum; the real risk is regulatory delay, not a pullback.

Workday, the enterprise software company, jumped nearly 19% in a single session last week on reports that Silver Lake was exploring a buyout, layered on top of genuine AI momentum — new contract value from its AI agent products is growing north of 200% year-over-year, and it just secured a federal authorization that will open the door to US government agency customers. Wells Fargo raised its target on the AI story alone, but Morgan Stanley cut the stock to underweight, arguing the rally has outrun the fundamentals. Workday reports earnings August 27, one day after Nvidia.

Data as of market close, August 19, 2026.
Educational research only, not investment advice. Stay sharp.

The 30-year Treasury yield hit a 19-year high and knocked equities lower, but breadth stays intact — this reads as rotation out of crowded rate-sensitive winners, not a market top.

The Signal
Equities slipped Tuesday as chip and software names led the retreat while the Dow barely moved, all in reaction to a bond market growing genuinely nervous. The 30-year Treasury yield hit 5.33%, its highest level in nineteen years, after the Fed's July meeting produced a 9-3 vote to hold rates steady, with all three dissents wanting a hike, not a cut. A new, largely untested Fed chair and firm oil prices on Iran tensions added to the unease. Long-duration, growth-sensitive stocks absorbed the pain first.

The Noise
None of this looks like a market rolling over. Broad money flow into stocks still runs well ahead of what's leaving, and trend readings across the board stay solidly bullish. What's shifted is where the crowding sits: financial stocks have re-priced hard on the idea that higher long rates help bank and insurer profits, and defensive health care names, bid up earlier this year as a rate-scare hiding place, are quietly losing that bid. Neither sector looks broken, both look crowded. That's rotation, not a top.

Multi-Signal Confluence
UDR, the apartment REIT, just raised full-year guidance on 96.6% occupancy and became the first residential REIT to pay dividends monthly, with new apartment supply nationally finally slowing. Its stock got knocked to a real discount against its own trend on the day the 30-year hit a fresh high, purely on rate sensitivity, even as recent pullbacks have gotten shallower.

State Street just posted record fee revenue and net interest income, EPS up more than two-thirds year over year, and raised its own outlook — Wall Street still rates it a buy. But the stock has run so far, so fast, that it now sits well above its own longer-term trend, with buying pressure clearly fading even as price keeps making new highs, a good business turned crowded trade.

NetApp has had a genuinely strong year, shares up over 50% year to date on real AI-storage demand and a May earnings beat, but the last few sessions show buying interest fading right at the highs, a pattern shared by the wider AI server hardware group heading into Nvidia's August 26 earnings, the month's biggest catalyst. Positioning, not panic.

Data as of the August 18 close.
Educational research only, not investment advice. Stay sharp.

Every confirmed reversal signal today pointed bearish, the most one-sided reading in weeks, spreading from health care and tech into financials, while the only fresh buying anywhere sits in defensive consumer staples.

The Signal
All three major indexes slipped Monday, snapping the S&P's three-week winning streak, while volatility jumped off its 2026 low even as it stays cheap by historical standards. Oil pushed toward eighty eight dollars a barrel on renewed US-Iran tension, and the thirty-year Treasury yield touched its highest level in decades. The biggest single-stock move was Microsoft, down three percent after a Wall Street note questioned whether enough advanced chip supply exists to support the AI capital spending tech companies have already committed to, an industry-wide digestion story rather than a company-specific one. Rate risk stayed unusual too: traders see under a one-in-three chance of a September hike, but July's meeting was a nine-to-three vote to hold, with three officials pushing for a hike.

The Noise
Broad money flow and price structure both still lean bullish, the slow, trend-confirming reads that say the primary uptrend remains intact. But every confirmed reversal candle today, all of them, pointed lower, and money-flow divergences ran better than five to one bearish, one of the most one-sided readings in weeks. That bearish tilt clusters hardest in health care and technology, with financials a close third, a textbook distribution signature of fresh price highs on thinning buying pressure. The only fresh accumulation anywhere in the universe sits in defensive consumer staples. Money isn't leaving the market, it's rotating out of this year's most crowded winners and into names nobody's been watching, a rotation reading rather than a top, though the setup argues for selling into strength rather than chasing it.

Multi-Signal Confluence
Zoetis plunged after last week's earnings, when revenue came in roughly flat and management cut full-year guidance well below Wall Street's expectations, as US pet-clinic visits soften and competition intensifies; several analysts cut their price targets in response. Yet two signals just turned bullish, price structure and money flow both diverging higher even as shares stayed oversold, a classic capitulation setup. The company also named a new chief financial officer effective today, one more unknown landing as the technical picture tries to stabilize.

The bearish counterpart sits in the same sector: Waters Corporation, whose fundamentals look close to flawless. Revenue and earnings both beat comfortably, management raised full-year guidance, and an analyst raised its price target right after the print. Yet a confirmed bearish reversal candle, a fresh bearish money-flow divergence, and price structure stretched into new highs on thinning buying pressure say the stock may simply be priced too perfectly for its own good.

The highest-conviction signal in today's scan is Bank of America, where every signal agrees, bearish, the strongest alignment in the report. The business is firing on all cylinders: earnings beat solidly last quarter, net income jumped double digits, and the bank pledged a quarter-trillion dollars to US infrastructure spending, with shares touching an all-time high just days ago. But a confirmed bearish reversal candle, a fresh bearish divergence, and a stock trading well above the model's fair value after a steady climb argue for caution rather than chasing the move.

Data as of the August 17 close.
Educational research only, not investment advice. Stay sharp.

Every confirmed reversal signal this week pointed bearish and clustered in this year's crowded winners, while defensive staples quietly saw inflows, as the market heads into its biggest retail-earnings week of the summer.

The Signal
All three major indexes slipped slightly to close out the week but still finished higher than where they started, with volatility sitting low and calm. The backdrop stayed friendly: July's inflation report cooled on both headline and core readings, and wholesale prices were soft too, keeping the case for eventual Fed easing alive. The complication is July retail sales, which posted their worst month in over a year, setting up a heavy stretch of consumer-facing earnings and a Federal Reserve meeting-minutes release in the week ahead.

The Noise
Broad money flow and price structure both still lean bullish, the slow, trend-confirming reads that say the primary uptrend is intact. But every confirmed reversal pattern this week pointed lower, and money-flow divergences ran roughly five to one bearish, concentrated almost entirely in health care, consumer discretionary, and technology, this rally's most crowded winners. The handful of bullish divergences sit almost entirely in defensive consumer staples. Money quietly rotating from extended leadership into unloved defensives, with the broad trend still intact, reads as rotation inside a healthy market rather than a top.

Multi-Signal Confluence
Target reports earnings Wednesday morning after a fifty-seven percent run this year and a beat streak averaging nearly seventeen percent over its last two quarters, with Wall Street expecting another year-over-year earnings gain near ten percent. But a confirmed bearish reversal candle, a fresh bearish money-flow divergence, and a deeply overbought reading all fired at once, with a downside target roughly five percent below Friday's close. A great track record can still be priced for perfection walking into a print.

Procter and Gamble is the bullish counterpart: a single fresh money-flow divergence shows quiet buying even as the stock trades slightly above the model's fair value. The company has paid a dividend for a hundred and thirty six years, just raised it for the seventieth straight year, and recently agreed to pay three point eight billion dollars for supplement maker Thorne. Yet one research firm just downgraded it to Hold, citing management's own guidance for another year of low single digit growth.

Home Depot, reporting Tuesday, is the more conflicted setup: the model sees it trading at a meaningful discount to its own fair-value target even as a lone bearish money-flow signal just fired. Shares are down more than ten percent over the past year, badly lagging the market, with a leadership shift landing days before earnings and a slow housing market weighing on demand.

Week Ahead
Home Depot kicks off Tuesday, Target and Lowe's follow Wednesday alongside the Federal Reserve's meeting minutes, and Walmart closes out the retail wave Thursday as the cleanest read on the broad consumer. Friday brings the start of the Jackson Hole symposium, with the bigger event, the Fed chair's keynote, landing the following week.

Data as of the August 14 close.
Educational research only, not investment advice. Stay sharp.